Home / Products / Cancer (Tumor) Cell Lines / REH
REH
Datasheet Protocol

REH

Cat. No. ARC0760
Product Type:

Cancer (Tumor) Cell Lines

Species:

Homo sapiens (Human)

Tissue Source:

Blood (peripheral blood)

Growth Properties:

Suspension

In stock
$1,300.00 / Vial
Ask a Question

Short Description 🔒

REH is a cancer cell line of acute lymphoblastic leukemia (all), isolated from in situ; peripheral blood.

Recommended Products

ENDOD1 Knockout KYSE150 Polyclonal Cells ENDOD1 Knockout KYSE150 Polyclonal Cells Cat. No. ARG12265 CHEK2 Knockout T47D Polyclonal Cells CHEK2 Knockout T47D Polyclonal Cells Cat. No. ARG11958 AKAP8 Knockout Raji Polyclonal Cells AKAP8 Knockout Raji Polyclonal Cells Cat. No. ARG21113 ACTL6B Knockout HAP1 Polyclonal Cells ACTL6B Knockout HAP1 Polyclonal Cells Cat. No. ARG21609 IFNAR2 Knockout NCI-H1299 Polyclonal Cells IFNAR2 Knockout NCI-H1299 Polyclonal Cells Cat. No. ARG30797 PEAK1 Knockout A549 Polyclonal Cells PEAK1 Knockout A549 Polyclonal Cells Cat. No. ARG10144
Product Details
Cell Engineering
Immortalization
Culture Conditions
Quality Control
Disclaimer

Product Details

Product Type:
Cancer (Tumor) Cell Lines
Species:
Homo sapiens (Human)
Tissue Source:
Blood (peripheral blood)
Disease:
Acute lymphoblastic leukemia (ALL)
Morphology:
Lymphoblast-like
Growth Mode:
Suspension
Sex of Donor:
Female
Derived From Site:
In situ; Peripheral blood
Size/Quantity:
1 million
Shipping info:
Cryopreserved in vials and shipped on dry ice

Cell Engineering Information

No cell engineering information available.

Immortalization Information

No immortalization information available.

Culture Conditions

Temperature:
37°C
Atmosphere:
5% CO₂

Quality Control

Mycoplasma testing:
Negative for mycoplasma through PCR analysis
Sterility testing:
Daily monitoring confirms that the cells are free from bacterial, yeast, and fungal contamination.
Pathogens:
Cells tested negative for HIV-1, HBV, and HCV.

Disclaimer

Intended Use:
This product is intended for laboratory in vitro use only. It is not intended for diagnostic, therapeutic, or clinical applications.
Disclaimer:
Ascent Research endeavors to provide accurate and up-to-date product information. However, no warranties or representations are made regarding its completeness or reliability.
Usage:
By accepting this product, the customer acknowledges and agrees to assume all risks associated with its receipt, handling, storage, disposal, and use. This product is provided "AS IS".

Description 🔒

Complete description is available upon request.

Related Products You May Also Like

BTBD18 Knockout HAP1 Polyclonal Cells

BTBD18 Knockout HAP1 Polyclonal Cells

Cat. No. ARG22137
 LY96 Knockout A2780 Polyclonal Cells

LY96 Knockout A2780 Polyclonal Cells

Cat. No. ARG18415
 STON2 Knockout 6-10B Cell Line

STON2 Knockout 6-10B Cell Line

Cat. No. ARG44143
 GPR171 Knockout HCT116 Polyclonal Cells

GPR171 Knockout HCT116 Polyclonal Cells

Cat. No. ARG36033
 ARHGEF2 Knockout HEK293T Polyclonal Cells

ARHGEF2 Knockout HEK293T Polyclonal Cells

Cat. No. ARG38197
 Li-7 Luciferase Stable Cell Line

Li-7 Luciferase Stable Cell Line

Cat. No. ARG0496